Axelar AB

4 clinical trials · Sponsor

Record	Firm	Date
A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors (NCT01725555)	Axelar AB	2012-10-01
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung (NCT01561456)	Axelar AB	2011-12-01
A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) (NCT01466647)	Axelar AB	2011-01-01
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer (NCT01062620)	Axelar AB	2008-04-01

Every clearance here is in the API, with alerts when new ones post.